Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and cys(11)-cys(15)-endothelin-1 (11-21)

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with cys(11)-cys(15)-endothelin-1 (11-21) in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(cys(11)-cys(15)-endothelin-1 (11-21))
Trials
(cys(11)-cys(15)-endothelin-1 (11-21))
Recent Studies (post-2010) (cys(11)-cys(15)-endothelin-1 (11-21))
9,1561875524400

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Koster, BM; Elferink, JG1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and cys(11)-cys(15)-endothelin-1 (11-21)

ArticleYear
Modulation of human neutrophil chemotaxis by the endothelin-B receptor agonist sarafotoxin S6c.
    Chemico-biological interactions, 1996, Sep-06, Volume: 101, Issue:3

    Topics: Calcium; Chemotaxis, Leukocyte; Cytoplasm; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelins; Humans; Interleukin-8; Leukotriene B4; Lymphocyte Activation; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Peptide Fragments; Peptides, Cyclic; Platelet Activating Factor; Receptors, Endothelin; Vasoconstrictor Agents; Viper Venoms

1996